Basilea Pharmaceutica AG (LON:0QNA)
London · Delayed Price · Currency is GBP · Price in CHF 58.53
+0.67 (1.16%)
Feb 12, 2026, 5:09 PM GMT
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 676.01 million as of February 12, 2026. Its market cap has increased by 60.16% in one year.
Market Cap
676.01M
Enterprise Value
646.01M
Revenue
216.79M
Ranking
n/a
PE Ratio
10.14
Stock Price
58.53
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 231.10M to 676.01M, an increase of 192.52%. That is a compound annual growth rate of 5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 676.01M | 7.13% |
| Dec 30, 2025 | 631.01M | 42.90% |
| Dec 30, 2024 | 441.59M | 12.00% |
| Dec 29, 2023 | 394.28M | -19.52% |
| Dec 30, 2022 | 489.93M | 24.72% |
| Dec 30, 2021 | 392.83M | -17.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Oxford Nanopore Technologies | 1.40B |
| Oxford Biomedica | 998.08M |
| CVS Group | 977.97M |
| Spire Healthcare Group | 814.80M |